CompoAtlas

Rinorub Pastilles gorge

Food supplement declared in France, declaration No 2023-3-826, decision dated 20 March 2023

Rinorub Pastilles gorge (Laboratoires Forté Pharma) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Laboratoires Forté Pharma
Food business operator placing the product on the market
Laboratoire FORTE PHARMA SA
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Pastille
Daily dose
4 pastilles
Directions for use
A partir de 12 ans: prendre 4 pastilles à sucer par jour.
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Utilisation prolongée
Objectives stated by the manufacturer (these are not authorised claims)
Voies respiratoires

Declaration 242077, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Sisymbrium officinale (L) Scop.Parties aériennesExtrait sec aqueux125 mg
Malva sylvestris L.FeuilleExtrait sec aqueux100 mg
Eucalyptus globulus Labill.FeuilleExtrait sec aqueux40 mg
Eucalyptus globulus Labill.Essence (feuille)Distillation15 mg
Mentha x piperita L.Essence (parties aériennes)Distillation10 mg
Citrus sinensis (L.) OsbeckEssence (épicarpe, zeste)Distillation5 mg

Other active ingredients

NamePer day
mielnot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg

Additives

E1202, E341, E504, E470b, E551, E420, E955, E421, E460, E1208

Other ingredients

menthol

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Il est conseillé de demander l’avis d’un professionnel desanté avant toute supplémentation. Il est conseillé aux femmesenceintes ou allaitantes de demander conseil à un professionnel desanté avant toute supplémentation. Déconseillé aux personnesallergiques aux produits de la ruche, ayant de l’asthme ou un terrain atopique (miel). Déconseillé aux personnes asthmatiques, épileptiques, aux personnes souffrant d’hypertension ou ayant des antécédents de convulsion sans l’avis d’un professionnel de santé. Ne pas dépasser un mois de prise (huiles essentielles). Demandez conseil à un professionnel de santé en cas d'obstruction des voies biliaires (calculs), de reflux gastro-œsophagiens, ou de troubles hépatopancréatiques (huile essentielle de menthe poivrée).Ce complément alimentaire n’est pas un médicament.Une consommation excessive peut avoir des effets laxatifs.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Mentha x piperita L.
    Read the warning, when it applies and the studies cited

    PEPPERMINT - MENTHA X PIPERITA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have gallstones or anemia (Brinker 2010; Mills and Bone 2005; Blumenthal et al. 2000).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Essential oil.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have hiatus hernia or gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: Essential oil.

    When using this product you may experience gastroesophageal reflux (Brinker 2010; Mills and Bone 2005; ESCOP 2003).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 27 February 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Laboratoires Forté Pharma

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line